Growth Metrics

Privia Health (PRVA) Return on Sales (2020 - 2025)

Privia Health (PRVA) has 6 years of Return on Sales data on record, last reported at 0.02% in Q4 2025.

  • For Q4 2025, Return on Sales rose 1.0% year-over-year to 0.02%; the TTM value through Dec 2025 reached 0.01%, changed 0.0%, while the annual FY2025 figure was 0.01%, 0.0% changed from the prior year.
  • Return on Sales reached 0.02% in Q4 2025 per PRVA's latest filing, up from 0.02% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.05% in Q4 2022 and bottomed at 0.77% in Q2 2021.
  • Average Return on Sales over 5 years is 0.04%, with a median of 0.01% recorded in 2024.
  • Peak YoY movement for Return on Sales: plummeted -80bps in 2021, then skyrocketed 73bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.04% in 2021, then skyrocketed by 207bps to 0.05% in 2022, then crashed by -89bps to 0.01% in 2023, then skyrocketed by 122bps to 0.01% in 2024, then surged by 67bps to 0.02% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.02% in Q4 2025, 0.02% in Q3 2025, and 0.01% in Q2 2025.